LONDON (AFX) - Antisoma PLC announced that R1549, its lead drug formerly known as Pemtumomab, has failed to meet its primary endpoint in a Phase III study in ovarian cancer.

The group, which specialises in the development of novel products for the treatment of cancer, said that the outcome for R1549-treated patients appeared no better than those of patients in the comparative arm of the SMART (Study of Monoclonal Antibody RadioimmunoTherapy) trial.

"Given these findings, it is unlikely that development of R1549 will continue," Antisoma said in a statement today.

The group is co-developing a number of drugs, including R1549, with Swiss pharmaceutical group Roche under the broad strategic alliance formed in November 2002.

"The outcome of this study will have no impact on our growth outlook and we remain committed to our long-term relationship with Antisoma, which is based upon multiple products," William Burns, Head of Roche's Pharmaceuticals Division said.

"Drug development is a high-risk endeavour and such results are not unexpected in the development of novel treatment modalities," he added.

etain.lavelle@afxnews.com

el/bam

So let us get this straightyou got in yesterday at 8p ...claiming the stock was oversoldit ended the day at 8p.so to concluded 8p was good value and 8p wasnt.I get it you could run 26 miles with ease but dont do marathons because the last couple of hundred yards takes it out of you.

Got in at 8.25 got out at 9.75 made enough to pay your council rent for a year.

Clubmanyour wastedjoin a circus!

Tabby stick to being a chav, you are no comedien

Long on this one got a gut feeling.

Me too!

All we need now is Cynic on board and it will fly

Tabby Invesco Limited upped holding by 5,000,000 plus and three director buys in the last 30 mins.

Nice 8% profit in one day Tabby

Think I may take my profit ahead of USA none farm payroll data due later today. As they say a grand in the hand is worth two in bush.

With the large spreadI dont know where you are going to get anywhere near 8%
and on less than 12,000 traded?

Did not buy on spreadbet, purchased 10,000 paid 0.5 tax and 12.50 broker fee
Bought @ 5.58 sold @ 6.00

Top and bottom thenwell doneIll wait..

I think it will rise again but am worried about NFP data in US @ 13.30 and it is dreaded Friday again.

Advised to add again todayyet to show

On my watchlist Tabby

A nice 10.58% profit today for Clubby

Antisoma plc ... will be announcing its Preliminary Results for the year ended 30 June
2010 on Thursday 29 July 2010.

Quietly gathering momentumlarge gains in the last couple of days.a good sign leading to the Prelims..I have high hopes with this one!a good punt at a good price

very nice Tabby please don't jinx it with any b*** talk